Thomas Diliberti, MD
Orthopedic Surgery · Dallas, TXNPI 1205908589
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (49.2%), education and travel and lodging — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Pylant Medical at 55.9% of the total. Reporting peaked in 2019 at $1,818 and has fallen 73.2% since, to $487 in 2025.
Across 72 payments — averaging $61.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pylant Medical$2K
- Arthrex$484
- Axogen$423
- Integra Lifesciences Corporation$223
- Stryker$163
- Medartis Inc.$152
- plus $500 from 11 others
What the payments were for
- Travel & lodging$1,04024%
- Food & beverage$2,17249%
- Education$1,20027%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pylant Medical | 11 | $2,467 |
| Arthrex | 11 | $484 |
| Axogen | 14 | $423 |
| Integra Lifesciences Corporation | 8 | $223 |
| Stryker | 3 | $163 |
| Medartis Inc. | 2 | $152 |
| Smith+Nephew | 4 | $95 |
| Orthofix Medical, Inc. | 5 | $89 |
| Endo Pharmaceuticals Inc. | 3 | $76 |
| Extremity Medical | 2 | $48 |
| Vertex | 2 | $46 |
| Bioventus LLC | 1 | $34 |
| Amgen | 2 | $32 |
| Acumed LLC | 1 | $30 |
| Endo USA, Inc. | 1 | $21 |
| Pacira Pharmaceuticals Incorporated | 1 | $15 |
| Sonex Health, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- APTUS$139
How this compares
$4,412 in reported general payments places this provider in the 65th percentile of 33 orthopedic surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 49 | $163 |
| Tramadol Hcl | 16 | $13 |
Paid to pharmacies, not to this prescriber.
Other orthopedic surgery in Dallas
- Hugh FrederickDallas$33
- Steven BrotzmanAustin$336K
- Rajesh ArakalPlano$79K
- Mark ScioliLubbock$70K
- John SimsAmarillo$35K
- Katherine LiHouston$19K
- Jason RamseyLubbock$13K
- Michael MarkowitzPlano$13K
- Mark GreenbergIrving$9K
- Bradley HarmanCleburne$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.